Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus (Abstract)
Low-dose naltrexone as treatment for epidermolysis bullosa pruriginosa-associated refractory pruritus Case Reports; JAAD Case Rep 19 June 2023 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339115/ A rare subtype of epidermolysis bullosa, epidermolysis bullosa pruriginosa (EBP) is characterized by severely pruritic lichenified and hypertrophic prurigo-like nodules and plaques secondary to chronic itching. No standard first-line therapy currently exists. Reported is a case of […]
Ray Solano, RPh – LDN Radio Show August 2023 (LDN; low dose naltrexone)
Welcome to the LDN Radio Show brought to you by the LDN Research Trust. I’m your host Linda Elsegood. Today we’re joined by Ray Solano from PD Labs. He’s also a nutritionist. Could you tell us a bit of background about yourself? I am dedicated to getting out the word on personalized medications. We […]
The LDN Book 3 (LDN; low dose naltrexone)
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details
Dosing of Low Dose Naltrexone (LDN)
Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone (Abstract)
Recalcitrant Hailey-Hailey Disease Successfully Treated with Low-dose Naltrexone J Clin Aesthet Dermatol November 2020 https://www.academia.edu/79471188/Recalcitrant_Hailey_Hailey_Disease_Successfully_Treated_with_Low_dose_Naltrexone?email_work_card=title Hailey-Hailey (HHD), or benign familial chronic pemphigus disease, is a rare autosomal dominant blistering disorder characterized by recurrent vesicles that erode and macerate into weeping and crusting plaques. HHD has been shown to be resistant to several treatment options. Although […]
Sleep Issues and Low Dose Naltrexone (LDN)
Recalcitrant cases of Hailey-Hailey disease successfully managed with low-dose naltrexone
Recalcitrant cases of Hailey-Hailey disease successfully managed with low-dose naltrexone Int J Dermatol 02 July 2022 https://pubmed.ncbi.nlm.nih.gov/35780232/ No abstract available
The Immune System and Low Dose Naltrexone (LDN)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone)
LDN Webinar 18 May 2022 (LDN; low dose naltrexone) LDN Questions Answered Live by Pharmacist Dr Masoud Rashidi – LDN Specialist Dr Sato-Re Dr Mathewson Sponsored by Innovative Compounding Pharmacy icpfolsom.com